Drug-associated reversible granulomatous T cell dyscrasia: a distinct subset of the interstitial granulomatous drug reaction.

TitleDrug-associated reversible granulomatous T cell dyscrasia: a distinct subset of the interstitial granulomatous drug reaction.
Publication TypeJournal Article
Year of Publication2010
AuthorsMagro CM, Cruz-Inigo AE, Votava H, Jacobs M, Wolfe D, A Crowson N
JournalJ Cutan Pathol
Volume37 Suppl 1
Pagination96-111
Date Published2010 Apr
ISSN1600-0560
KeywordsAged, Aged, 80 and over, Angiotensin-Converting Enzyme Inhibitors, Anticonvulsants, Antidepressive Agents, Biopsy, Drug Eruptions, Female, Granuloma, Humans, Lymphoma, T-Cell, Cutaneous, Male, Middle Aged, Precancerous Conditions, Skin Neoplasms, T-Lymphocytes
Abstract

BACKGROUND: A cutaneous T-cell infiltrate exhibiting cytologic and architectural atypia, an aberrant phenotypic profile and clonal restriction would fall under the rubric of a T-cell dyscrasia. Although such an infiltrate could represent a lymphoma, this constellation of findings can also be seen in drug-associated pseudolymphoma.

METHODS: In 2001, two of the authors (CMM and AEC) proposed the term reversible T-cell dyscrasia to describe atypical T-lymphocytic infiltrates that manifest a light microscopic, phenotypic and molecular profile that closely parallels cutaneous T-cell lymphoma but regress when the causal drug is withdrawn.

RESULTS: Herein we report our 10 cases of drug-associated pseudolymphoma resembling granulomatous mycosis fungoides.

CONCLUSIONS: We term this reaction pattern drug-associated reversible granulomatous T-cell dyscrasia and consider it a distinct subset of the interstitial granulomatous drug reaction.

DOI10.1111/j.1600-0560.2010.01518.x
Alternate JournalJ Cutan Pathol
PubMed ID20482682
Related Faculty: 
Cynthia M. Magro, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700